Literature DB >> 18085509

Structuring and interactions of human beta-defensins 2 and 3 with model membranes.

Francesca Morgera1, Nikolinka Antcheva, Sabrina Pacor, Luca Quaroni, Federico Berti, Lisa Vaccari, Alessandro Tossi.   

Abstract

beta-Defensins play an important role in both innate and adaptive immunity, displaying a direct anti-microbial activity against a wide variety of micro-organisms as well as interesting immuno-modulatory effects on host cells. Interaction with biological membranes appears to be a central theme in modulating these activities, leading to different consequences such as membrane lysis, translocation into the cytoplasm or transfer to a receptor. We have investigated the structuring of human beta-defensins (hBD2 and hBD3) and rationally designed variants, in relation to their interactions with real and model membranes. Biophysical methods, such as circular dichroism (CD), transmission or reflection IR and dye release were used to probe their structure/activity in the presence of model membranes, while fluorimetric and flow cytometric assays were used to investigate the effects on prokaryotic cells. Our results indicate that structural features, such as the helical N-terminal domains and oligomerisation at the membrane surface, may modulate the efficiency of membrane insertion and selectivity for microbial or host-cell membranes. We propose that both peptides interact with membranes as extended beta-sheet platforms that present amphipathic helices for insertion into the lipid bilayer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18085509     DOI: 10.1002/psc.981

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  10 in total

1.  Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci.

Authors:  Vera Sass; Tanja Schneider; Miriam Wilmes; Christian Körner; Alessandro Tossi; Natalia Novikova; Olga Shamova; Hans-Georg Sahl
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

2.  Human beta-defensin-2 increases cholinergic response in colon epithelium.

Authors:  Nina Himmerkus; Veit Vassen; Birte Sievers; Boeren Goerke; Qixian Shan; Jürgen Harder; Jens-Michael Schröder; Markus Bleich
Journal:  Pflugers Arch       Date:  2010-03-06       Impact factor: 3.657

3.  Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.

Authors:  Paulina Schmitt; Miriam Wilmes; Martine Pugnière; André Aumelas; Evelyne Bachère; Hans-Georg Sahl; Tanja Schneider; Delphine Destoumieux-Garzón
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

4.  Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria.

Authors:  Joanna Kraszewska; Michael C Beckett; Tharappel C James; Ursula Bond
Journal:  Appl Environ Microbiol       Date:  2016-06-30       Impact factor: 4.792

5.  Human β-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity.

Authors:  Himanshu Sharma; Ramakrishnan Nagaraj
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

6.  Variations in the interaction of human defensins with Escherichia coli: Possible implications in bacterial killing.

Authors:  Basil Mathew; Ramakrishnan Nagaraj
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

7.  Plant defensin antibacterial mode of action against Pseudomonas species.

Authors:  Andrew E Sathoff; Shawn Lewenza; Deborah A Samac
Journal:  BMC Microbiol       Date:  2020-06-19       Impact factor: 3.605

8.  Real-Time Fluorescence Microscopy on Living E. coli Sheds New Light on the Antibacterial Effects of the King Penguin β-Defensin AvBD103b.

Authors:  Céline Landon; Yanyu Zhu; Mainak Mustafi; Jean-Baptiste Madinier; Dominique Lelièvre; Vincent Aucagne; Agnes F Delmas; James C Weisshaar
Journal:  Int J Mol Sci       Date:  2022-02-12       Impact factor: 5.923

9.  Modification of β-Defensin-2 by Dicarbonyls Methylglyoxal and Glyoxal Inhibits Antibacterial and Chemotactic Function In Vitro.

Authors:  Janna G Kiselar; Xiaowei Wang; George R Dubyak; Caroline El Sanadi; Santosh K Ghosh; Kathleen Lundberg; Wesley M Williams
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

Review 10.  Multitarget Approaches against Multiresistant Superbugs.

Authors:  Declan Alan Gray; Michaela Wenzel
Journal:  ACS Infect Dis       Date:  2020-03-19       Impact factor: 5.084

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.